2007
DOI: 10.1016/j.bbrc.2007.01.031
|View full text |Cite
|
Sign up to set email alerts
|

γδT cells kill myeloma cells by sensing mevalonate metabolites and ICAM-1 molecules on cell surface

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
55
0

Year Published

2009
2009
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 56 publications
(56 citation statements)
references
References 19 publications
1
55
0
Order By: Relevance
“…The cells have antigen recognition properties and effect the regulation of immune response through cell contact dependent mechanism and secretion of cytokines (Uchida et al, 2007). Previous studies have reported that Τ cells cultured from human peripheral blood may be vital in anticancer surveillance (Campillo et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…The cells have antigen recognition properties and effect the regulation of immune response through cell contact dependent mechanism and secretion of cytokines (Uchida et al, 2007). Previous studies have reported that Τ cells cultured from human peripheral blood may be vital in anticancer surveillance (Campillo et al, 2007).…”
Section: Discussionmentioning
confidence: 99%
“…If the threshold icer is CA$100,000 per qaly, the estimated probability that zoledronic acid is where sres are typically defined as hypercalcemia, pathologic fracture, spinal cord compression, and radiotherapy to bone 2 . Several bisphosphonates have also demonstrated anticancer activity in preclinical models [3][4][5][6][7][8] . A randomized controlled trial comparing conventional chemotherapy therapy alone with zoledronic acid 4 mg intravenously once every 28 days plus conventional chemotherapy in 94 previously untreated multiple myeloma patients reported a significant benefit on overall survival (os) with the addition of zoledronic acid 9 .…”
Section: Resultsmentioning
confidence: 99%
“…Subsequent to these seminal papers, other groups have shown that MM Vc9Vd2 T cells can be induced to recognize and kill myeloma and lymphoma cells upon stimulation with NBPs or s-pAgs such as IPP and BrHPP [6,7,46,48,49]. We have shown that ZA induced the activation and proliferation of peripheral blood Vc9Vd2 T cells via autologous monocytes, which serve as endogenous IPP producers, and by enhancing the immunosensitivity of myeloma cells to Vc9Vd2 T cells.…”
Section: Preclinical Evidences Of Antitumor Vc9vd2 T Cell Activity Inmentioning
confidence: 95%
“…The intracellular cell adhesion molecule-1 (ICAM-1) is another cell surface molecule playing a key role in Vc9Vd2 T cell-mediated myeloma cell recognition and killing [46]. Uchida et al have shown that the susceptibility of RPMI 8226 and U266 myeloma cell lines to the cytotoxic activity of Vc9Vd2 T cells requires both recognition of the Mev pathway metabolites, and expression of ICAM-1.…”
Section: Expression Of Nkg2d Ligands and Other Tcr-independent Targetmentioning
confidence: 99%